Literature DB >> 33284539

National Consensus on Non-metastatic Castration-Resistant Prostate Cancer: more than just a snapshot.

Leonardo Oliveira Reis1,2, Luciana Saboya Brito Dal Col1,2, Marcus Vinícius Sadi3.   

Abstract

Entities:  

Year:  2021        PMID： 33284539      PMCID： PMC7857765          DOI： 10.1590/S1677-5538.IBJU.2020.0249.1

Source DB:  PubMed          Journal:  Int Braz J Urol        ISSN： 1677-5538            Impact factor:   1.541


× No keyword cloud information.
  8 in total

Review 1.  Comparative efficacy of apalutamide darolutamide and enzalutamide for treatment of non-metastatic castrate-resistant prostate cancer: A systematic review and network meta-analysis.

Authors:  Jatinder Kumar; Seyed Behzad Jazayeri; Shiva Gautam; Daniel Norez; Muhammad Umar Alam; Karthik Tanneru; Soroush Bazargani; Joseph Costa; Mark Bandyk; Hariharan Palayapalayam Ganapathi; Shahriar Koochekpour; K C Balaji
Journal:  Urol Oncol       Date:  2020-06-28       Impact factor: 3.498

2.  Financial Conflict of Interest and Academic Influence Among Experts Speaking on Behalf of the Pharmaceutical Industry at the US Food and Drug Administration's Oncologic Drugs Advisory Committee Meetings.

Authors:  Austin Lammers; Jonathan Edmiston; Victoria Kaestner; Vinay Prasad
Journal:  Mayo Clin Proc       Date:  2017-07       Impact factor: 7.616

3.  Metastasis-free Survival-Progress or Lowering the Bar on Nonmetastatic Prostate Cancer?

Authors:  Leonardo O Reis
Journal:  Eur Urol       Date:  2018-08-28       Impact factor: 20.096

4.  ARN-509: a novel antiandrogen for prostate cancer treatment.

Authors:  Nicola J Clegg; John Wongvipat; James D Joseph; Chris Tran; Samedy Ouk; Anna Dilhas; Yu Chen; Kate Grillot; Eric D Bischoff; Ling Cai; Anna Aparicio; Steven Dorow; Vivek Arora; Gang Shao; Jing Qian; Hong Zhao; Guangbin Yang; Chunyan Cao; John Sensintaffar; Teresa Wasielewska; Mark R Herbert; Celine Bonnefous; Beatrice Darimont; Howard I Scher; Peter Smith-Jones; Mark Klang; Nicholas D Smith; Elisa De Stanchina; Nian Wu; Ouathek Ouerfelli; Peter J Rix; Richard A Heyman; Michael E Jung; Charles L Sawyers; Jeffrey H Hager
Journal:  Cancer Res       Date:  2012-01-20       Impact factor: 12.701

5.  Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019.

Authors:  Silke Gillessen; Gerhardt Attard; Tomasz M Beer; Himisha Beltran; Anders Bjartell; Alberto Bossi; Alberto Briganti; Rob G Bristow; Kim N Chi; Noel Clarke; Ian D Davis; Johann de Bono; Charles G Drake; Ignacio Duran; Ros Eeles; Eleni Efstathiou; Christopher P Evans; Stefano Fanti; Felix Y Feng; Karim Fizazi; Mark Frydenberg; Martin Gleave; Susan Halabi; Axel Heidenreich; Daniel Heinrich; Celestia Tia S Higano; Michael S Hofman; Maha Hussain; Nicolas James; Ravindran Kanesvaran; Philip Kantoff; Raja B Khauli; Raya Leibowitz; Chris Logothetis; Fernando Maluf; Robin Millman; Alicia K Morgans; Michael J Morris; Nicolas Mottet; Hind Mrabti; Declan G Murphy; Vedang Murthy; William K Oh; Piet Ost; Joe M O'Sullivan; Anwar R Padhani; Chris Parker; Darren M C Poon; Colin C Pritchard; Robert E Reiter; Mack Roach; Mark Rubin; Charles J Ryan; Fred Saad; Juan Pablo Sade; Oliver Sartor; Howard I Scher; Neal Shore; Eric Small; Matthew Smith; Howard Soule; Cora N Sternberg; Thomas Steuber; Hiroyoshi Suzuki; Christopher Sweeney; Matthew R Sydes; Mary-Ellen Taplin; Bertrand Tombal; Levent Türkeri; Inge van Oort; Almudena Zapatero; Aurelius Omlin
Journal:  Eur Urol       Date:  2020-01-27       Impact factor: 20.096

6.  Prostate-Specific Membrane Antigen Ligand Positron Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer.

Authors:  Matthias Eiber; Boris Hadaschik; Wolfgang P Fendler; Manuel Weber; Amir Iravani; Michael S Hofman; Jérémie Calais; Johannes Czernin; Harun Ilhan; Fred Saad; Eric J Small; Matthew R Smith; Paola M Perez; Thomas A Hope; Isabel Rauscher; Anil Londhe; Angela Lopez-Gitlitz; Shinta Cheng; Tobias Maurer; Ken Herrmann
Journal:  Clin Cancer Res       Date:  2019-09-11       Impact factor: 12.531

7.  Consensus on diagnosis and management of non-metastatic castration resistant prostate cancer in Brazil: focus on patient, selection, treatment efficacy, side effects and physician's perception according to patient comorbidities.

Authors:  Fernando Maluf; Andrey Soares; Guilherme Avanço; Aline Lury Hada; Ana Paula Garcia Cardoso; Arie Carneiro; Daniel Herchenhorn; Denis Leonardo Fontes Jardim; Fabio Augusto Schutz; Fabio Roberto Kater; Felipe Moraes Toledo Pereira; Fernando Sabino Marques Monteiro; Igor Alexandre Protzner Morbeck; João Francisco Navarro Reolon; Karine Martins da Trindade; Livia Maria Querino da Silvo Andrade; Lucas Mendes Nogueira; Renato Furoni; Ricardo Azze Natel; Rodolfo Borges Dos Reis; Rodrigo Nogueira Fogace; Vinicius Carrera Souza
Journal:  Int Braz J Urol       Date:  2021 Mar-Apr       Impact factor: 1.541

8.  Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis.

Authors:  Keiichiro Mori; Hadi Mostafaei; Benjamin Pradere; Reza Sari Motlagh; Fahad Quhal; Ekaterina Laukhtina; Victor M Schuettfort; Mohammad Abufaraj; Pierre I Karakiewicz; Takahiro Kimura; Shin Egawa; Shahrokh F Shariat
Journal:  Int J Clin Oncol       Date:  2020-09-14       Impact factor: 3.402
  8 in total
  2 in total

1.  Treatment of complex urethral stenosis in public centers from developing countries in 21st century.

Authors:  Dane E Klett; Manaf Alom; Kevin Wymer; Aaron Potretzke
Journal:  Int Braz J Urol       Date:  2022 Mar-Apr       Impact factor: 3.050

2.  Perception of castration value over cost in the metastatic prostate cancer scenario: a contemporary pharmacoeconomic perspective.

Authors:  Luciana Saboya Brito Dal Col; Danilo L Andrade; Lucas M Gon; Diego M Capibaribe; Marcelo P Amaro; Natássia C C Truzzi; Barbara R Malkomes; Leonardo O Reis
Journal:  Int Braz J Urol       Date:  2022 Jan-Feb       Impact factor: 1.541
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.